Janssen Therapeutics - Articles and news items

Janssen Pharmaceuticals Logo

FDA grants accelerated approval for SIRTURO™ (bedaquiline)

Industry news, News / 31 December 2012 / Johnson & Johnson

FDA has granted accelerated approval to SIRTURO™ Tablets for the treatment of pulmonary multi-drug resistant tuberculosis…

Janssen Pharmaceuticals Logo

Edurant™ 96-Week Phase 3 safety and efficacy data presented

Industry news, News / 19 July 2011 / Janssen Therapeutics

Janssen Therapeutics, presented 96-week findings from two pivotal Phase 3 clinical trials…

 

The deadline for submissions to the EPR Awards is 9 June 2017! Entry is FREE, so don't delay...
+